Omni Bio Pharmaceutical Inc (OTCMKTS:OMBP) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.00 and traded as high as $0.01. Omni Bio Pharmaceutical shares last traded at $0.01, with a volume of 61,500 shares traded.
About Omni Bio Pharmaceutical (OTCMKTS:OMBP)
Omni Bio Pharmaceutical, Inc operates as a biopharmaceutical company in the United States. It holds a license to use patent for the treatment of diabetes using plasma-derived alpha-1 antitrypsin (p-AAT), a protein that is purified from human blood. The company also holds licenses for the use of patents and patent applications covering the use of p-AAT in the treatment of cellular transplantation and graft rejection, radiation protection, bacterial and viral diseases, myocardial remodeling, and inflammatory bowel disease indications.
Further Reading: Basic Economics creates winners and losers
Receive News & Ratings for Omni Bio Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omni Bio Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.